Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
about
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancerHypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyThioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression.Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.The emerging role of the thioredoxin system in angiogenesisA cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cells.Comparison of angiogenesis-related factor expression in primary tumor cultures under normal and hypoxic growth conditions.A combined patch-clamp and electrorotation study of the voltage- and frequency-dependent membrane capacitance caused by structurally dissimilar lipophilic anionsAntitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.Basal and angiotensin II-inhibited neuronal delayed-rectifier K+ current are regulated by thioredoxin.Iodine mediated oxidative cross-coupling of unprotected anilines and heteroarylation of benzothiazoles with 2-methylquinoline.
P2860
Q22000765-63D0A402-9527-465A-8F76-2678355A6EC2Q33950665-BB780016-81D3-4383-AE5B-3323628C8F1DQ34442273-4E11C39F-1FAB-4A3C-9BAE-FA8240318EA4Q34619502-6AE9891D-EE92-486C-AECC-F5E1447F9DACQ35123800-C0C1D100-39FE-4766-9A14-53E60115B178Q36358122-3280DF52-8271-4E1B-8A9F-3B831AB9485BQ36742816-386B4BF3-C2E4-47BE-9E05-12AAF13A2163Q36775533-35ED29A1-6B62-4D0B-B1E8-19EAA770A4CAQ37371780-9947A44C-775A-49A1-8C32-5B41C4BBE392Q41781992-CA531993-410F-4B1F-875C-8536DCC6805EQ42509598-11153336-DE23-4742-88B2-11862A4970CCQ50179126-331B3E7C-8199-4BBF-B91E-2D2F8AE655DA
P2860
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cytotoxic and antiangiogenic a ...... inhibitor: an in vitro study.
@en
type
label
Cytotoxic and antiangiogenic a ...... inhibitor: an in vitro study.
@en
prefLabel
Cytotoxic and antiangiogenic a ...... inhibitor: an in vitro study.
@en
P2093
P2860
P356
P1476
Cytotoxic and antiangiogenic a ...... inhibitor: an in vitro study.
@en
P2093
A D Westwell
A Mukherjee
J Carmichael
M F G Stevens
S G Martin
T D Bradshaw
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602338
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1044023653